Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…
Poll
Women's Healthcare Newsletter
Enter your email to receive our bi-weekly newsletter from the publishers of Women's Healthcare